New episodes publish every Tuesday at 5 a.m. ET.
Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.
All content for Breastcancer.org Podcast is the property of Breastcancer.org and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
New episodes publish every Tuesday at 5 a.m. ET.
Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.
Antibody-drug conjugates (ADCs) are a relatively new type of medicine for breast cancer. Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Dato-DXd (brand name: Datroway) are two ADCs used to treat breast cancer.
Dr Benjamin Schrank and colleagues have developed a new type of ADC that combines an antibody with a toxin — called an antibody-toxin conjugate — that teaches the immune system to recognize and attack cancer cells.
Listen to the episode to hear Dr. Schrank explain:
the antibody and the toxin component of the medicine
how the new medicine works
possible side effects
next steps for the research
Episode image photo credit: The University of Texas MD Anderson Cancer Center
Breastcancer.org Podcast
New episodes publish every Tuesday at 5 a.m. ET.
Covering everything from the latest breast cancer treatments to the rising costs of care to what it’s like to be diagnosed when you’re pregnant, The Breastcancer.org Podcast explores all things breast cancer. Join host and veteran science reporter Jamie DePolo as she talks to world-renowned oncologists, breast cancer advocates, and everyday people affected by breast cancer. Guests have included oncologists Hope Rugo, Dennis Slamon, and Eleonora Teplinsky, as well as advocates from METAvivor, Breast Cancer Action, SHARE, and GRASP. The Breastcancer.org Podcast is produced by Breastcancer.org, a nonprofit organization dedicated to providing the most reliable and up-to-date information about breast cancer. Learn more about breast cancer and join our community at www.breastcancer.org.
